bluebird bio Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cost of Revenue	0.1	0.07	0.24	-	-
Gross Profit	-0.1	-0.07	-0.24	-	-
Selling, General & Admin	1.02	0.96	0.56	0.01	0.01
Other Operating Expenses	0.16	0.27	0.12	-	-
Operating Expenses	1.28	1.45	0.87	0.04	0.02
Operating Income	-1.37	-1.51	-1.11	-0.04	-0.02
Interest & Investment Income	0.07	0.1	0.01	-	-
Other Non Operating Income (Expenses)	-0.09	-0.12	-0.11	-	-
Pretax Income	-1.4	-1.54	-1.21	-0.04	-0.02
Net Income	-1.4	-1.54	-1.21	-0.04	-0.02
Net Income to Common	-1.4	-1.54	-1.21	-0.04	-0.02
Shares Outstanding (Basic)	59	57	8	9	-
Shares Outstanding (Diluted)	59	57	8	9	-
Shares Change (YoY)	590.16%	645.54%	-9.48%	-	-
EPS (Basic)	-0.02	-0.03	-0.16	-0.01	-
EPS (Diluted)	-0.02	-0.03	-0.16	-0.01	-
Free Cash Flow	-2.06	-3.77	-1.33	-0.03	-0.02
Free Cash Flow Per Share	-0.04	-0.07	-0.17	-0.00	-
EBITDA	-1.35	-1.5	-	-	-
D&A For EBITDA	0.02	0.01	-	-	-
EBIT	-1.37	-1.51	-1.11	-0.04	-0.02
Revenue as Reported	0.1	0.1	0.01	-	-

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.